Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
11/2003
11/12/2003EP0583378B1 Combined calcium and vitamin d supplements
11/12/2003CN1455661A New cosmetic, personal care, cleaning agent and nutritional supplement compositions containg bioactive glass and methods of making and using same
11/12/2003CN1455285A Anion spectacle frame
11/12/2003CN1454662A Wart-removing ointment
11/12/2003CN1454626A Chinese herbal medicine for enhancing immunity
11/12/2003CN1454616A Medicine for curing haemorrhoids
11/12/2003CN1454607A Medicine for curing cervicitis and preparing method thereof
11/12/2003CN1127346C Leukoderma treating externally-used medicine
11/11/2003US6645988 Pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors with fast acting buffer; gastric acid stability for enteral administration
11/11/2003US6645535 Method of making coated chewing gum products containing various antacids
11/11/2003US6645532 Compositions and method for relieving discomfort in the ears
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/11/2003US6645518 Uses for medical devices having a lubricious, nitric oxide-releasing coating
11/11/2003CA2321306C Oral care compositions comprising chlorite
11/09/2003CA2385774A1 Composition to reduce food cravings and supress the appetite
11/06/2003WO2003090778A2 Dna vaccine combined with an inducer of tumor cell apoptosis
11/06/2003WO2003090766A1 Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans
11/06/2003WO2003090759A1 Difructose anhydride-containing composition and use thereof
11/06/2003WO2003090756A1 Anti-acne compositions and methods of use
11/06/2003WO2003090671A2 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
11/06/2003WO2003075685A3 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
11/06/2003WO2003061574A3 Prevention of cisplatin induced deafness
11/06/2003WO2003061556A3 Ingestible capsaicin neutralizer
11/06/2003WO2003020642B1 Precipitated aragonite and a process for producing it
11/06/2003WO2003005966A3 Topical medicine and process and apparatus for making same
11/06/2003WO2003004064A3 Products for treating ovarian cancers and for preventing relapses
11/06/2003WO2002002063A8 Promoting whole body health
11/06/2003US20030207942 Hydroxycitric acid salt composition and method of making
11/06/2003US20030207847 Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
11/06/2003US20030207028 Substrate with a photocatalytic coating
11/06/2003US20030206971 Aqueous acidulant part comprising an activator acid, a rheology modifier or a pseudoplastic thickener, a chlorine dioxide stable visual indicator system; alkali metal chlorite
11/06/2003US20030206970 Ophthalmic compositions containing galactomannan polymers and borate
11/06/2003US20030206969 Prenatal multivitamin/multimineral supplement
11/06/2003US20030206967 Sodium metasilicate, borax,sodium thiosulfate, potassium carbonate, refined cane sugar and water; improvement in disease resistance, weight gain rate, crop yield, crop quality, and harvest time
11/06/2003US20030206966 Methods of inducing apoptosis and modulating metalloproteinases
11/06/2003US20030206965 Allergen neutralization compositions
11/06/2003US20030206963 Bone resorption suppressing agent
11/06/2003US20030206874 Promoting whole body health
11/06/2003CA2480268A1 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
11/05/2003EP1357977A2 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia
11/05/2003EP1357951A1 A medical dressing comprising an antimicrobial silver compound
11/05/2003EP1357936A1 BIOCATALYTIC AND BIOMIMETIC GENERATION OF NITRIC OXIDE i IN SITU /i AT SUBSTRATE/BLOOD INTERFACES
11/05/2003EP1357935A2 Method of reducing side effects of chemotherapy in cancer patients
11/05/2003EP1357920A2 Compositions and method of tissue superoxygenation
11/05/2003EP1001792B1 Use of physiologically acceptable vanadium compounds, salts and complexes
11/05/2003EP0921807B1 Hydrogenous medicament
11/05/2003EP0656366B1 Iron-lactoferrin combination and process for producing the same
11/05/2003CN1454090A Compositions and methods for improving cardiovascular function
11/05/2003CN1454084A Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
11/05/2003CN1453036A Quick-acting ointment for treating burns, scalds and knife wound
11/05/2003CN1452995A Externally applied paste for treating fracture and injured tendons
11/05/2003CN1452992A Externally applied psoriasis-treating medicine and its prepn
11/05/2003CN1126563C External-applied medicine for treating acne
11/05/2003CN1126562C Preparation for treating phlebeaurysma and preparing method thereof
11/05/2003CN1126557C Medicine for treating diabetes and its preparing process
11/05/2003CN1126551C Chinese herb medicine for treating coronary heart disease
11/05/2003CN1126550C Chinese herb medicine solution for treating anal firstula
11/05/2003CN1126549C Pharmaceutical composition containing nitric oxide
11/04/2003US6643488 Intermediate transfer drum for electro-photographic process and image forming apparatus using the same
11/04/2003US6642221 Vanadium compounds as anti-proliferative agents
11/04/2003US6642202 Egg having active oxygen eliminating ability and method of producing same
11/04/2003US6642017 Modulating production of pneumococcal capsular polysaccharide
11/04/2003US6641842 Thermoplastic articles exhibiting high surface-available silver
11/04/2003US6641824 Skin treatment using a new retinoid
10/2003
10/30/2003WO2003089568A2 Method of inhibiting restenosis
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003088983A1 Use of topical compositions for the control of microbial diseases of the nail
10/30/2003WO2003088982A1 Device and method for treating restenosis with zinc
10/30/2003WO2003088981A1 Methods of treating necrotizing enterocolitis
10/30/2003WO2003088976A1 Method for treating and preventing hyperparathyroidism
10/30/2003WO2003088965A1 Use of materials having zinc ionophoric behavior
10/30/2003WO2003088960A1 Anti-tumour agents
10/30/2003WO2003088957A1 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
10/30/2003WO2003088923A2 Methods of treating ileus
10/30/2003WO2003088901A2 Oral rehydration composition
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003051294A3 Mitocidal compositions and methods
10/30/2003WO2003047697A3 Use of an farsenyl protein tranferase inhibitor in combination with other antineoplastic agents for the manufacture of a medicament against cancer
10/30/2003WO2003047633A3 Treatment of angiogenesis disorders using targeted nanoparticles
10/30/2003WO2003047603A3 Breathable gas mixtures to change body temperature
10/30/2003WO2003045404A3 Treatment and diagnosis of diseases associated with adverse levels of zinc, cadmium and calcium
10/30/2003WO2003043569A3 Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases
10/30/2003WO2003032899A3 Methods and materials for targeting and affecting selected cells
10/30/2003WO2003026679A3 Saline solutions for clinical or cosmetic use
10/30/2003WO2002012131A3 Antioxidants in clusters of structured water
10/30/2003WO2002007700A8 Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
10/30/2003US20030203976 Anti-angiogenic compositions and methods of use
10/30/2003US20030203973 Administering triethylenetetramine to lower copper value of myocardium; for treatment of diabetes
10/30/2003US20030203961 A taxane joined by a hydrolyzable bond to one or more oligomers that containing a polyethylene glycol group and a tert-amide group
10/30/2003US20030203956 Method of using a cyclooxygenase-2 inhibitor and one or more ornithine decarboxylase inhibitors as a combination therapy in the treatment of neoplasia
10/30/2003US20030203060 Electrodeposition of very fine metal particles, e.g. copper, in a plant extract juice by electrolysis using the desired metal as an electrode to form a medicinal powder; refining of alloys, e.g., removal of gold metal from an alloy (jewelry)
10/30/2003US20030203051 Plant extracts for the treatment of increased bone resorption
10/30/2003US20030203048 Oral administration to counteract dehydration resulting from vomiting, diarrhea, physical exercise or illness; especially suitable for infants, small children and the elderly; water, sodium, potassium, citrate, carbonate and structuring
10/30/2003US20030203047 Composition and method for increasing testosterone levels
10/30/2003US20030203046 Solutions and aerosols of metal-containing compounds
10/30/2003US20030203045 Therapeutic composition for the treatment of HIV-1 and HIV-2
10/30/2003US20030203044 Wound-treating gel
10/30/2003US20030203043 Composition and method for increasing testosterone levels
10/30/2003US20030203035 Using film forming drug to control dusts
10/30/2003US20030203026 Compressed tablet containing non-steroid antiinflammatory drug